Price $233.61 |
Market Cap
7.89B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
62.6
|
P/B
10.89
|
P/S
3.98
|
Dividend %
-
|
|
P/CF
48.3
|
P/FCF
31.4
|
Op. Cash Flow
262.6K
|
FCF
7.7
|
|
Op. Margin
9.20%
|
Net Margin
6.50%
|
ROE
19.40%
|
ROI
15.30%
|
|
ROA
9.20%
|
EPS Growth
2.40%
|
Current Ratio
1.1
|
Debt/Equity
36.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Bioanalytical Systems, Inc. (BASI) | $4.85 | - | - | 51.6M | Strong Buy |
| Endo International PLC (ENDP) | $3.26 | - | - | 641.2M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $2.94 | - | - | 70.1M | Strong Buy |
| Teva Pharmaceutical Industries (TEVA) | $9.48 | - | - | 10.43B | Strong Buy |
| ImmuCell Corporation (ICCC) | $5.65 | - | - | 38.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
